Browsing by Author Stockler, Martin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 146  next >
Issue DateTitleAuthor(s)Citation
2014Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)Boland, Amy; Chatfield, Mark; Gebski, Val; Grimison, Peter; Houghton, Baerin; Stockler, Martin; et al, Various; Friedlander, Michael; Gruney, H; Kichenadasse, G; Lewis, Craig; Rosenthal, M; Singhal, N; Thomson, D B; Toner, Guy C.; Vasey, P; Wong, S; Northern Clinical School: Medicine; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAccelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Annals of Oncology, vol.25, 1, 2014,pp 143-148
2004Acetaminophen (Paracetamol) Improves Pain And Well-Being In People With Advanced Cancer Already Receiving A Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial.Stockler, Martin; Pillai, Avinesh; Vardy, Janette; Warr, David; School of Public Health: NH&MRC Clinical Trials CentreAcetaminophen (Paracetamol) Improves Pain And Well-Being In People With Advanced Cancer Already Receiving A Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial., Journal of Clinical Oncology, vol.22,(16),2004,pp 3389-3394
2005Achieving equal standards in medical student education: is a national exit examination the answer?Stockler, Martin; Tattersall, Martin; Barton, Michael B.; Coventry, Brendon J; Dewar, Joanna M.; Koczwara, Bogda; Millar, Jeremy L.; Olver, I; Schwarz, Max A.; Starmer, Darren L.; Turner, David; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineAchieving equal standards in medical student education: is a national exit examination the answer?, Medical Journal of Australia 2005, vol.182,(5),2005,pp 228-230
2010Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?Beale, Philip; Blinman, Prunella; Clarke, Stephen; Duric, Vlatka; Hudson, Malcolm; Stockler, Martin; Boyce, Adam; Briscoe, Karen; Goldstein, David; Nowak, Anna K.; Central Clinical School: Medicine; School of Public Health: Public Health; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?, European Journal of Cancer, vol.46, 10, 2010,pp 1800-1807
2002Adjuvant mitoxantrone chemotherapy for men at high risk of relapse following radical prostatectomy: a pilot studyBoyer, Michael; Stockler, Martin; Eisinger, D; Goad, J; Rosenthal, M; Webb, D; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant mitoxantrone chemotherapy for men at high risk of relapse following radical prostatectomy: a pilot study, UroOncology, vol.2,(1),2002,pp 15-17
2010Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?Chim, Lesley; Kelly, Patrick John; Salkeld, Glenn; Stockler, Martin; School of Public Health: Public Health; School of Public Health: Medicine; School of Public Health: Public Health; NH&MRC Clinical Trials CentreAre Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?, PharmacoEconomics, vol.28, 6, 2010,pp 463-475
2004Assessing Quality Of Life During Chemotherapy For Pleural Mesothelioma: Feasibility, Validity, And Results Of Using The European Organization For Research And Treatment Of Cancer Core Quality Of Life Questionnaire And Lung Cancer Module.Nowak, Anna; Stockler, Martin; Byrne, Michael J.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssessing Quality Of Life During Chemotherapy For Pleural Mesothelioma: Feasibility, Validity, And Results Of Using The European Organization For Research And Treatment Of Cancer Core Quality Of Life Questionnaire And Lung Cancer Module., Journal of Clinical Oncology, vol.22,(15),2004,pp 3172-3180
2008Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinomaDhillon, Haryana; Gebski, Val; Hargreaves, Carol; Nowak, Anna; Stockler, Martin; Cebon, Jonathon; Findlay, Michael; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, vol.4, N/A, 2008,pp 55-67
2015Barriers to radiotherapy utilisation in New South Wales Australia: Health professionals’ perceptions of impacting factorsCosta, Daniel; King, Madeleine; Milross, Christopher; Stockler, Martin; Sundaresan, Purnima (Puma); Psychology; Psychology; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: MedicineBarriers to radiotherapy utilisation in New South Wales Australia: Health professionals’ perceptions of impacting factors, Journal of Medical Imaging and Radiation Oncology, vol.59, N/A, 2015,pp 535-541
2017Barriers to radiotherapy utilization: Consumer perceptions of issues influencing radiotherapy-related decisionsCosta, Daniel; King, Madeleine; Milross, Christopher; Stockler, Martin; Sundaresan, Purnima (Puma); Northern Clinical School: Medicine; Psychology; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Barriers to radiotherapy utilization: Consumer perceptions of issues influencing radiotherapy-related decisions, Asia-Pacific Journal of Clinical Oncology, vol.13, 5, 2017,pp e489-e496
2005Beauty is in the eye of the examiner: reaching agreement about physical signs and their value.Celermajer, David; Joshua, A; Stockler, Martin; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreBeauty is in the eye of the examiner: reaching agreement about physical signs and their value., Internal Medicine Journal 2005, vol.35,(3),2005,pp 178-187
2003The benefits and costs of tamoxifen for breast cancer preventionEckermann, Simon; Martin, Andrew; Simes, Robert John; Stockler, Martin; School of Public Health: NH&MRC Clinical Trials Centre; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe benefits and costs of tamoxifen for breast cancer prevention, Australian and New Zealand Journal of Public Health, vol.27,(1),2003,pp 34-40
2013Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancerBlinman, Prunella; Boyer, Michael; McCaughan, G; Stockler, Martin; School of Public Health: Public Health; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreBetter estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer, Internal Medicine Journal, vol.43, 4, 2013,pp 424-429
2013Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literatureHruby, George; Kench, James; Stockler, Martin; Gzell, C; Central Clinical School: Medicine; School of Medical Sciences: Pathology; School of Public Health: NH&MRC Clinical Trials CentreBiopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature, International Urology and Nephrology, vol.45, 3, 2013,pp 735-742
2017Bisphosphonates and other bone agents for breast cancerGoodwin, Annabel; O'Carrigan, Brent; Pavlakis, Nick; Stockler, Martin; Willson, Melina; Wong, Matthew H.F.; Concord Clinical School: Medicine; Central Clinical School: Medicine; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBisphosphonates and other bone agents for breast cancer, Cochrane Database of Systematic Reviews, vol.2017, 10, 2017,pp 1-210
2005Bisphosphonates for breast cancer.Pavlakis, Nick; Schmidt, Robert; Stockler, Martin; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; School of Public Health: NH&MRC Clinical Trials CentreBisphosphonates for breast cancer., Cochrane Database of Systematic Reviews, vol.0,(3),2005,pp CD003474-N/A
2007Bs06 patient-rated outcome measures were more sensitive than clinician-rated measures at distinguishing the effects of sentinel node biopsy and axillary clearance in the snac trialGill, Peter; Simes, Robert John; Smith, Michaella; Sourjina, Tatiana; Stockler, Martin; Wetzig, Neil; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Medical Sciences: Physiology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreBs06 patient-rated outcome measures were more sensitive than clinician-rated measures at distinguishing the effects of sentinel node biopsy and axillary clearance in the snac trial, ANZ Journal of Surgery, vol.77,(Suppl. 1),2007,pp A2-A2
2011Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast CancerCoates, Alan; Gebski, Val; Grimison, Peter; Stockler, Martin; Wilcken, Nicholas; Zannino, Diana; Ackland, Stephen; Byrne, Michael J.; Fitzharris, B; Fong, A.; Forbes, John; Francis, Prudence; Gainford, Corona; Harvey, V; Nowak, Anna; Paksec, Lisa; Simes, John; Sourjina, Tatiana; Van Hazel, Guy; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials CentreCapecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer, Journal of Clinical Oncology, vol.29, 34, 2011,pp 4498-4504
2010Capecitabine, Bevacizumab and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized, Phase III MAX Study.Gebski, Val; Simes, Robert John; Stockler, Martin; Zannino, Diana; Ackland, Stephen P.; Broad, Adam; Chua, Yu Jo; Cummins, Michelle; Cunningham, David; Forgeson, Garry; Ganju, Vinod; Price, Timothy; Robinson, Bridget; Saunders, M; Tebbutt, Niall C; van Hazel, Guy; Wilson, Kate; Zalcberg, J; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCapecitabine, Bevacizumab and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized, Phase III MAX Study., Journal of Clinical Oncology (Online), vol.28, 19,pp 3191-3198
2003Chemotherapy for advanced breast cancer- how long should it continue?Coates, Alan; Stockler, Martin; Wilcken, Nicholas; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Chemotherapy for advanced breast cancer- how long should it continue?, Breast Cancer Research and Treatment, vol.81,(Suppl 1),2003,pp S49-S52